en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
2/2013
vol. 51
 
Share:
Share:
more
 
 
abstract:
Editorial

Autoimmune (auto-inflammatory) syndrome induced by adjuvants – ASIA

Yehuda Shoenfeld
,
Maria Maślińska

Reumatologia 2013; 51, 2: 101-107
Online publish date: 2013/04/29
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Adjuvants are essential in contemporary medicine for the enhancement of the immune response, the effect being particularly important in the case of vaccines. Adjuvants stimulate both the innate and the acquired immune response. The ideal adjuvant should increase the immune response without causing a specific immune response against itself or an adverse reaction. However, observations in recent years have shown the impact of adjuvants on the development of autoimmune inflammatory rheumatic diseases (AIIRD), as well as other recognized syndromes such as Gulf War syndrome (GWS), macrophagic myofasciitis (MMF), and fibromyalgia (FB). Many reports indicate that the use of silicone implants may also result in the development of the hyperreactive immune response known as ‘siliconosis’. It is proposed that these clinical situations – separate, yet at the same time displaying similar features – should be covered by a common definition: autoimmune/inflammatory syndrome induced by adjuvants (ASIA).
keywords:

adjuvant, immune response autoimmune diseases







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.